Search results
Results from the WOW.Com Content Network
Radioactive iodine (iodine-131) alone can potentially worsen thyrotoxicosis in the first few days after treatment. One side effect of treatment is an initial period of a few days of increased hyperthyroid symptoms. This occurs because when the radioactive iodine destroys the thyroid cells, they can release thyroid hormone into the blood stream.
Iodine-123 (123 I) is a radioactive isotope of iodine used in nuclear medicine imaging, including single-photon emission computed tomography (SPECT) or SPECT/CT exams. The isotope's half-life is 13.2232 hours; [1] the decay by electron capture to tellurium-123 emits gamma radiation with a predominant energy of 159 keV (this is the gamma primarily used for imaging).
Iodine-125 (125 I) is a radioisotope of iodine which has uses in biological assays, nuclear medicine imaging and in radiation therapy as brachytherapy to treat a number of conditions, including prostate cancer, uveal melanomas, and brain tumors. It is the second longest-lived radioisotope of iodine, after iodine-129.
There are 40 known isotopes of iodine (53 I) from 108 I to 147 I; all undergo radioactive decay except 127 I, which is stable. Iodine is thus a monoisotopic element.. Its longest-lived radioactive isotope, 129 I, has a half-life of 16.14 million years, which is far too short for it to exist as a primordial nuclide.
On March 24, 2011, Japanese officials announced that "radioactive iodine-131 exceeding safety limits for infants had been detected at 18 water-purification plants in Tokyo and five other prefectures". Officials said also that the fallout from the Dai-ichi plant is "hindering search efforts for victims from the March 11 earthquake and tsunami". [70]
The radioactive iodine uptake test is a type of scan used in the diagnosis of thyroid problems, particularly hyperthyroidism. It is entirely different from radioactive iodine therapy (RAI therapy), which uses much higher doses to destroy cancerous cells. The RAIU test is also used as a follow-up to RAI therapy to verify that no thyroid cells ...
Iodine-129 (129 I) is a long-lived radioisotope of iodine that occurs naturally but is also of special interest in the monitoring and effects of man-made nuclear fission products, where it serves as both a tracer and a potential radiological contaminant.
Sources cite 5,500 to 12,000 curies (200 to 440 TBq) of iodine-131 released, [1] [2] [3] and an even greater amount of xenon-133. The radiation was distributed over populated areas and caused the cessation of intentional radioactive releases at Hanford until 1962, when more experiments commenced. [3]